Eating slowly, chewing well, and taking time to finish meals can further increase GLP-1 and PYY levels
Circular motion helps dissolve without damaging the peptide
The incretin mimetics, glucagon-like peptide-1 receptor agonists (eg, semaglutide, liraglutide) and dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonist (ie, tirzepatide), demonstrate the greatest weight loss benefits, with tirzepatide achieving reductions exceeding 20% in some patients
Due to the medications extended half-life, approximately seven days, patients eventually reach a steady state, Dr
At-home NAD+ and B12 support may be worth discussing for eligible adults who want a practical way to continue a clinician-guided wellness routine between IV visits